statistical calculations, linear and non-linear regressions Search Results


90
GraphPad Software Inc non-linear regression analysis and a four-parameter logistic fit function provided by graphpad prism® 5.04 software
Non Linear Regression Analysis And A Four Parameter Logistic Fit Function Provided By Graphpad Prism® 5.04 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression analysis and a four-parameter logistic fit function provided by graphpad prism® 5.04 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression analysis and a four-parameter logistic fit function provided by graphpad prism® 5.04 software - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-parametric spearman’s correlations and linear regression analyses
Non Parametric Spearman’s Correlations And Linear Regression Analyses, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-parametric spearman’s correlations and linear regression analyses/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-parametric spearman’s correlations and linear regression analyses - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-linear regression and one-way anover analyses and plotting of data
Non Linear Regression And One Way Anover Analyses And Plotting Of Data, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression and one-way anover analyses and plotting of data/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression and one-way anover analyses and plotting of data - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc single exponential fits graphpad prism
Single Exponential Fits Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single exponential fits graphpad prism/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
single exponential fits graphpad prism - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
OriginLab corp linear and non-linear regression curve fitting originw 7.03
Linear And Non Linear Regression Curve Fitting Originw 7.03, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/linear and non-linear regression curve fitting originw 7.03/product/OriginLab corp
Average 90 stars, based on 1 article reviews
linear and non-linear regression curve fitting originw 7.03 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-linear regression one-site and two-site binding models derived from the cheng-prusoff equation graphpad prism version 5.0
Non Linear Regression One Site And Two Site Binding Models Derived From The Cheng Prusoff Equation Graphpad Prism Version 5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression one-site and two-site binding models derived from the cheng-prusoff equation graphpad prism version 5.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression one-site and two-site binding models derived from the cheng-prusoff equation graphpad prism version 5.0 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Verlag GmbH mastering calculations in linear and nonlinear mechanics
Mastering Calculations In Linear And Nonlinear Mechanics, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mastering calculations in linear and nonlinear mechanics/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
mastering calculations in linear and nonlinear mechanics - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc nonlinear regression curves and 80% neutralization titers (nt80)
a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and <t>neutralization</t> assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers <t>(NT80)</t> plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.
Nonlinear Regression Curves And 80% Neutralization Titers (Nt80), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression curves and 80% neutralization titers (nt80)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression curves and 80% neutralization titers (nt80) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd linear regression and non-parametric testing
a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and <t>neutralization</t> assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers <t>(NT80)</t> plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.
Linear Regression And Non Parametric Testing, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/linear regression and non-parametric testing/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
linear regression and non-parametric testing - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc fitting models to biological data using linear and nonlinear regression, a practical guide to curve fitting
a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and <t>neutralization</t> assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers <t>(NT80)</t> plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.
Fitting Models To Biological Data Using Linear And Nonlinear Regression, A Practical Guide To Curve Fitting, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitting models to biological data using linear and nonlinear regression, a practical guide to curve fitting/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
fitting models to biological data using linear and nonlinear regression, a practical guide to curve fitting - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-linear regression and curve comparison
a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and <t>neutralization</t> assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers <t>(NT80)</t> plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.
Non Linear Regression And Curve Comparison, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression and curve comparison/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression and curve comparison - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc sigmoidal non-linear regression half max calculations
a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and <t>neutralization</t> assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers <t>(NT80)</t> plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.
Sigmoidal Non Linear Regression Half Max Calculations, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sigmoidal non-linear regression half max calculations/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
sigmoidal non-linear regression half max calculations - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and neutralization assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers (NT80) plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.

Journal: Nature Communications

Article Title: SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

doi: 10.1038/s41467-020-18468-8

Figure Lengend Snippet: a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and neutralization assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers (NT80) plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.

Article Snippet: Nonlinear regression curves and 80% neutralization titers (NT80) were calculated in GraphPad Prism v8.

Techniques: Neutralization, Sampling, Activity Assay